Nexalin Technology, Inc.(NXL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NXL Nexalin Technology, Inc.

Pre-Mkt 04-23 09:19:44 EDT

1.74

+0.01

+0.35%

盘前1.82

+0.10+5.81%

09:19 EDT

High1.79	Low1.70	Vol48.19K
Open1.77	D1 Closing1.73	Amplitude5.19%
Mkt Cap23.15M	Tradable Cap18.81M	Total Shares13.30M
T/O84.67K	T/O Rate0.45%	Tradable Shares10.81M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"NXL","market":"US","secType":"STK","nameCN":"Nexalin Technology, Inc.","latestPrice":1.74,"timestamp":1745352000000,"preClose":1.734,"halted":0,"volume":48186,"hourTrading":{"tag":"盘前","latestPrice":1.82,"preClose":1.72,"latestTime":"09:19 EDT","volume":2011,"amount":3569.7150395,"timestamp":1745414340734},"delay":0,"floatShares":10812253,"shares":13303523,"eps":-0.825452,"marketStatus":"Pre-Mkt","change":0.006,"latestTime":"04-23 09:19:44 EDT","open":1.77,"high":1.79,"low":1.7,"amount":84667.10982839999,"amplitude":0.051903,"askPrice":1.98,"askSize":499,"bidPrice":1.16,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.825452,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745415000000},"marketStatusCode":1,"adr":0,"listingDate":1663300800000,"exchange":"NASDAQ","adjPreClose":1.72,"preHourTrading":{"tag":"盘前","latestPrice":1.82,"preClose":1.72,"latestTime":"09:19 EDT","volume":2011,"amount":3569.7150395,"timestamp":1745414340734},"postHourTrading":{"tag":"盘后","latestPrice":1.64,"preClose":1.74,"latestTime":"19:51 EDT","volume":342,"amount":563.22,"timestamp":1745365876404},"volumeRatio":0.26871754390059566},"requestUrl":"/m/hq/s/NXL/wiki","defaultTab":"wiki","newsList":[{"id":"2527842115","title":"Nexalin Secures Patent for Intracranial Stimulation Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2527842115","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527842115?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 00:59","pubTimestamp":1744649949,"startTime":"0","endTime":"0","summary":"Nexalin Technology  said Monday it secured a patent for its deep intracranial frequency stimulation technology in treating substance use disorders.The firm said the US Patent and Trademark Office granted its patent \"Alternating Current Dynamic Frequency Stimulation Method for Opioid Use Disorder and Substance Use Disorder.\"The technology may help regulate neural pathways linked to addiction and withdrawal symptoms, offering an alternative treatment pathway, Nexalin said.Price: 1.97, Change: +0.08, Percent Change: +4.23","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7016","BK4082","NXL","NXL.AU"],"gpt_icon":0},{"id":"2527115583","title":"Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2527115583","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527115583?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 00:30","pubTimestamp":1744648200,"startTime":"0","endTime":"0","summary":"Patent Approval Reinforces Nexalin’s Leadership in Non-Invasive Brain Stimulation for Addiction Treatment. HOUSTON, TX, April 14, 2025  -- Nexalin Technology, Inc.   the leader in Deep Intracranial Frequency Stimulation  of the brain, is pleased to announce that the United States Patent and Trademark Office  has officially granted its patent titled \"Alternating Current Dynamic Frequency Stimulation Method for Opioid Use Disorder  and Substance Use Disorder .\". This milestone further strengthens Nexalin’s intellectual property portfolio and affirms the potential of its proprietary Deep Intracranial Frequency Stimulation  technology, a non-invasive and drug-free solution designed to aid individuals struggling with substance use disorders , including opioid use disorder , alcohol use disorder , and stimulant addiction such as cocaine and methamphetamine dependence. By applying non-invasive deep-brain stimulation at dynamic frequencies, DIFS technology may help regulate neural pathways lin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nexalin-technology-secures-uspto-patent-163000456.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NXLIW","BK4082","BK4190","NXL","MAT"],"gpt_icon":0},{"id":"2526364374","title":"The Fallen: Stocks hitting 52-week lows (and what investors should do)","url":"https://stock-news.laohu8.com/highlight/detail?id=2526364374","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526364374?lang=en_us&edition=full_marsco","pubTime":"2025-04-10 10:48","pubTimestamp":1744253281,"startTime":"0","endTime":"0","summary":"Earlier this week, I covered The Outlaws – stocks hitting 52-week highs despite the market sinking.The Outlaw Stocks: The ASX names defying the sell-off and hitting 52-week highs. Unlike in 2022, when almost every asset class fell in lockstep, this year we’ve seen defensives and fixed income ETFs do what they’re meant to do: offer ballast in a storm.Now, let's flip the script and look at the stocks and ETFs which hit 52-week lows before today's bigger-than-Ben-Hur rally. We'll call them:The Fallen.To be sure, these aren’t necessarily all bad businesses. As fund managers like Emanuel Datt, Adam Dawes, and Nick Peros have pointed out, a stock hitting a 52-week low isn’t always a red flag.It's a potential opportunity to pick up quality at a discount.Due to the sheer number of names hitting 52-week low, we’ve  focused this wire on two key ASX sectors – resources and financials – with expert insights to help investors make sense of the wreckage.You can download the full list below or use th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/the-fallen-stocks-hitting-52-week-lows-and-what-investors-should-do","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/the-fallen-stocks-hitting-52-week-lows-and-what-investors-should-do","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK4552","BK7507","LU2471134879.HKD","LU2471134523.USD","MFG.AU","TNE.AU","LU1868837136.USD","BK7016","LU0314104364.USD","MQG.AU","NXL","LU0795875086.SGD","NDQ.AU","LU0170899867.USD","LU0742534661.SGD","LU2237438978.USD","LU2237443549.SGD","BK4127","PNI.AU","LU0912757837.SGD","IE00B19Z3B42.SGD","LU2089283258.USD","NXL.AU","RMD.AU","LU0795875169.SGD","LU0158827948.USD","RIO.AU","XRO.AU","RMD","LU1162221912.USD","LU2023251221.USD","REA.AU","LU1548497426.USD","BK4585","BHP.AU","MIN.AU","CSL.AU","LU2089284900.SGD","LU0225283273.USD","LU2237443978.SGD","LU2028103732.USD","GQG.AU","BK4516","BK7508","LU2471134796.USD","LU2008162690.USD","LU1732800096.USD","LU0251131958.USD","BK4550","BK7002"],"gpt_icon":0},{"id":"2524985504","title":"Nexalin Technology Enrolls First Patients and Advances Toward Treatment in Ucsd Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2524985504","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524985504?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 20:30","pubTimestamp":1743597031,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nFWN3QG0D7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXL","BK4082"],"gpt_icon":0},{"id":"2524493820","title":"Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2524493820","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524493820?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 20:30","pubTimestamp":1743597000,"startTime":"0","endTime":"0","summary":"HOUSTON, TX, April 02, 2025  -- Nexalin Technology, Inc.   the leader in Deep Intracranial Frequency Stimulation  of the brain, today announced that it has successfully enrolled the first patients in its clinical trial at the University of California, San Diego , in collaboration with the VA San Diego Healthcare System . The company began treatment of the first patients this week with the Nexalin HALO.The trial follows the recent successful shipment and integration of Nexalin’s HALO Clarity devices at UCSD, where they are being used to provide non-invasive, at-home neurostimulation therapy with AI-integrated remote monitoring. Nexalin’s Electronic Data Capture  platform and Patient Monitoring System  enable real-time tracking of patient adherence and treatment progress. As the study progresses, additional HALO Clarity devices will be deployed to ensure optimal patient coverage and data collection.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nexalin-technology-enrolls-first-patients-123000694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NXLIW","EDC","NXL","BK4082"],"gpt_icon":0},{"id":"2522808581","title":"Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2522808581","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522808581?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 20:30","pubTimestamp":1742992200,"startTime":"0","endTime":"0","summary":"Houston, TX, March 26, 2025  -- Nexalin Technology, Inc.   is pleased to invite investors to a webinar on April 3, 2025, at 4:15 p.m. ET.This press release contains statements that constitute \"forward-looking statements,\" These statements relate to future events or Nexalin’s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact  should be considered forward looking statements that involve risks and uncertainties which could cause actual events or Nexalin’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's Report on Form 10-K for the year ended Dece","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/join-nexalin-technology-exclusive-live-123000933.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NXL","NXLIW"],"gpt_icon":0},{"id":"2521747056","title":"Nexalin Technology Raised to Buy From Hold by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2521747056","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521747056?lang=en_us&edition=full_marsco","pubTime":"2025-03-24 20:10","pubTimestamp":1742818200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NXL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 24, 2025 08:10 ET (12:10 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXL"],"gpt_icon":0},{"id":"2519404368","title":"Nuix Limited's (ASX:NXL) 29% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio","url":"https://stock-news.laohu8.com/highlight/detail?id=2519404368","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519404368?lang=en_us&edition=full_marsco","pubTime":"2025-03-15 05:56","pubTimestamp":1741989417,"startTime":"0","endTime":"0","summary":"Unfortunately for some shareholders, the Nuix Limited ( ASX:NXL ) share price has dived 29% in the last thirty days...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/software/asx-nxl/nuix-shares/news/nuix-limiteds-asxnxl-29-dip-still-leaving-some-shareholders","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4082","NXL.AU","BK7016","NXL"],"gpt_icon":0},{"id":"2519801176","title":"Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV","url":"https://stock-news.laohu8.com/highlight/detail?id=2519801176","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519801176?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 21:00","pubTimestamp":1741957200,"startTime":"0","endTime":"0","summary":"ORLANDO, FL / ACCESS Newswire / March 14, 2025 / RedChip Companies will air interviews with Nexalin Technology, Inc.  and Calidi Biotherapeutics, Inc.  on the RedChip Small Stocks, Big Money show, a sponsored program on Bloomberg TV this Saturday, March 1, at 7 p.m. Eastern Time . Bloomberg TV is available in an estimated 73 million homes across the U.S.Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All of Nexalin's products are believed to be non-invasive and undetectable to the human body and are developed to provide relief to those afflicted with mental health issues. Nexalin utilizes bioelectronic medical technology to treat mental health issues. Nexalin believes its neurostimulation medical devices can penetrate structures deep in the mid-brain that are associated with mental health disorders. Nexalin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nexalin-technology-calidi-biotherapeutics-interviews-130000894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4100","BK4581","ET","TM","CLDI","BK4099","NXLIW","NXL","BK4144","AIRI","BK4585","BK4604","BK4187","03160","BK4561","BK4588","BK4555","BK4590","TV"],"gpt_icon":0},{"id":"2519852337","title":"Will Nexalin Technology (NASDAQ:NXL) Spend Its Cash Wisely?","url":"https://stock-news.laohu8.com/highlight/detail?id=2519852337","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519852337?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 20:32","pubTimestamp":1741955556,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-nxl/nexalin-technology/news/will-nexalin-technology-nasdaqnxl-spend-its-cash-wisely","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","TSYW.SI","BK4112","NQmain","BK4082","QID","SQQQ","NDAQ",".IXIC","NVIW.SI","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BKPKM429.USD","QLD","NXL","USJW.SI","MNQmain","IE00B64PRP62.GBP","LU2210149790.SGD","LU2210150020.SGD","TQQQ","USAW.SI","IE00BGHQF748.EUR","BK4585","PSQ"],"gpt_icon":1},{"id":"2514324296","title":"Nexalin Technology announces initiation of patient recruitment in UCSD study","url":"https://stock-news.laohu8.com/highlight/detail?id=2514324296","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514324296?lang=en_us&edition=full_marsco","pubTime":"2025-02-28 21:36","pubTimestamp":1740749765,"startTime":"0","endTime":"0","summary":"Nexalin Technology (NXL) announced that following Institutional Review Board, IRB, approval, the University of California, San Diego, UCSD, has rec...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nexalin-technology-announces-initiation-of-patient-recruitment-in-ucsd-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nexalin-technology-announces-initiation-of-patient-recruitment-in-ucsd-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXL","BK4082"],"gpt_icon":0},{"id":"2514321233","title":"Nexalin Technology Announces Initiation of Patient Recruitment for Ucsd’s Tbi & Ptsd Clinical Study Following Irb Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2514321233","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514321233?lang=en_us&edition=full_marsco","pubTime":"2025-02-28 21:30","pubTimestamp":1740749401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nTUA3NTNZP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NXL","NXLIW"],"gpt_icon":0},{"id":"2514285865","title":"Nexalin Technology appoints Wesley Clark to Military, Government Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2514285865","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514285865?lang=en_us&edition=full_marsco","pubTime":"2025-02-26 21:36","pubTimestamp":1740577010,"startTime":"0","endTime":"0","summary":"Nexalin Technology (NXL) announced that General Wesley Clark, former NATO Supreme Allied Commander Europe, has joined its Military & Government Adv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nexalin-technology-appoints-wesley-clark-to-military-government-advisory-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nexalin-technology-appoints-wesley-clark-to-military-government-advisory-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","NXL"],"gpt_icon":0},{"id":"2514306498","title":"Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2514306498","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514306498?lang=en_us&edition=full_marsco","pubTime":"2025-02-26 21:30","pubTimestamp":1740576601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nTUA8MKHWK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXLIW","NXL","BK4082"],"gpt_icon":0},{"id":"2514085880","title":"Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2514085880","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514085880?lang=en_us&edition=full_marsco","pubTime":"2025-02-26 21:30","pubTimestamp":1740576600,"startTime":"0","endTime":"0","summary":"HOUSTON, TX, Feb. 26, 2025  -- Nexalin Technology, Inc.   the leader in Deep Intracranial Frequency Stimulation  of the brain, is honored to announce that General Wesley K. Clark , former NATO Supreme Allied Commander Europe, has joined its Military & Government Advisory Board. General Clark will collaborate with esteemed members David F. Lasseter, former Deputy Assistant Secretary of Defense for Policy, and William A. Hudson, Jr., former Acting General Counsel to the Department of Veterans Affairs, to advance Nexalin's innovative neurostimulation solutions within U.S. military and government sectors. The Company’s on-going “Nexalin America” initiative includes addressing post-traumatic stress disorder, traumatic brain injury, substance use disorder, and other areas of significant concern to the U.S. government.Mark White, CEO of Nexalin Technology, stated, \"We are privileged to welcome General Clark to our Advisory Board, supporting our Nexalin America initiative. His unparalleled lea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nexalin-technology-welcomes-general-wesley-133000958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NXL","NXLIW","BK4082"],"gpt_icon":0},{"id":"2514095813","title":"Jefferies Reaffirms Their Buy Rating on Nuix Ltd. (NXL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514095813","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514095813?lang=en_us&edition=full_marsco","pubTime":"2025-02-25 20:21","pubTimestamp":1740486068,"startTime":"0","endTime":"0","summary":"Jefferies analyst Wei Sim maintained a Buy rating on Nuix Ltd. (NXL – Research Report) today and set a price target of A$6.10. The company’s shares...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-reaffirms-their-buy-rating-on-nuix-ltd-nxl?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-reaffirms-their-buy-rating-on-nuix-ltd-nxl?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXL"],"gpt_icon":0},{"id":"2514702489","title":"Nuix Ltd. (NXL) Gets a Buy from Shaw and Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2514702489","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514702489?lang=en_us&edition=full_marsco","pubTime":"2025-02-25 06:35","pubTimestamp":1740436543,"startTime":"0","endTime":"0","summary":"In a report released today, Jules Cooper from Shaw and Partners maintained a Buy rating on Nuix Ltd. (NXL – Research Report), with a price target o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/nuix-ltd-nxl-gets-a-buy-from-shaw-and-partners-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/nuix-ltd-nxl-gets-a-buy-from-shaw-and-partners-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4100","SJR","BK4082","NXL"],"gpt_icon":0},{"id":"2512166508","title":"BRIEF-Nexalin Technology Announces UCSD IRB Approval For Use Of HALO Clarity  In Clinical Trials For mTBI And PTSD Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166508","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512166508?lang=en_us&edition=full_marsco","pubTime":"2025-02-18 22:58","pubTimestamp":1739890711,"startTime":"0","endTime":"0","summary":"BRIEF-Nexalin Technology Announces UCSD IRB Approval For Use Of HALO Clarity  In Clinical Trials For mTBI And PTSD TreatmentFeb 18 (Reuters) - Nexalin Technology Inc NXL.O:NEXALIN TECHNOLOGY ANNOUNCES","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nTUAZWQDH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXL","NXLIW","BK4082"],"gpt_icon":0},{"id":"2512916324","title":"Nexalin Technology Says Halo Clarity Headset Clinical Testing Gets UCSD Institutional Review Board Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2512916324","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512916324?lang=en_us&edition=full_marsco","pubTime":"2025-02-18 22:28","pubTimestamp":1739888922,"startTime":"0","endTime":"0","summary":"Nexalin Technology  said Tuesday that the University of California in San Diego Institutional Review Board has approved the use of its Halo Clarity headset in human subjects in clinical trials.The headsets will be tested in clinical trials to assess their efficacy in treating mild traumatic brain injury and post-traumatic stress disorder, particularly in military personnel, the company said.The company and its manufacturing partner have begun preparing the initial shipment of 50 headsets to the university, which is conducting the study independently, Nexalin said.Nexalin said the headset is a non-invasive treatment that can be used at home and allows physicians to monitor patient progress remotely.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NXL.AU","NXL","BK7016","BK4082"],"gpt_icon":0},{"id":"2512150903","title":"Nexalin Technology’s HALO Clarity headset approved for use in trials by UCSD","url":"https://stock-news.laohu8.com/highlight/detail?id=2512150903","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512150903?lang=en_us&edition=full_marsco","pubTime":"2025-02-18 21:40","pubTimestamp":1739886054,"startTime":"0","endTime":"0","summary":"Nexalin Technology (NXL) has received Institutional Review Board – IRB – approval from the University of California, San Diego, or UCSD, for clinic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nexalin-technologys-halo-clarity-headset-approved-for-use-in-trials-by-ucsd?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nexalin-technologys-halo-clarity-headset-approved-for-use-in-trials-by-ucsd?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXL","HALO","BK4139","BK4082","LU0053671581.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nexalin.com","stockEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.2689},{"period":"3month","weight":-0.3507},{"period":"6month","weight":-0.1907},{"period":"1year","weight":0.0675},{"period":"ytd","weight":-0.3696}],"compareEarnings":[{"period":"1week","weight":-0.0193},{"period":"1month","weight":-0.0651},{"period":"3month","weight":-0.1306},{"period":"6month","weight":-0.0898},{"period":"1year","weight":0.0551},{"period":"ytd","weight":-0.1004}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.","exchange":"NASDAQ","name":"Nexalin Technology, Inc.","nameEN":"Nexalin Technology, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nexalin Technology, Inc.(NXL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Nexalin Technology, Inc.(NXL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Nexalin Technology, Inc.,NXL,Nexalin Technology, Inc.股票,Nexalin Technology, Inc.股票老虎,Nexalin Technology, Inc.股票老虎国际,Nexalin Technology, Inc.行情,Nexalin Technology, Inc.股票行情,Nexalin Technology, Inc.股价,Nexalin Technology, Inc.股市,Nexalin Technology, Inc.股票价格,Nexalin Technology, Inc.股票交易,Nexalin Technology, Inc.股票购买,Nexalin Technology, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nexalin Technology, Inc.(NXL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Nexalin Technology, Inc.(NXL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction